144 related articles for article (PubMed ID: 38434975)
21. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
23. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
[TBL] [Abstract][Full Text] [Related]
24. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
25. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
[TBL] [Abstract][Full Text] [Related]
26. Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis.
Gao L; Feng Y; Ge C; Xu X; Wang S; Li X; Zhang K; Wang C; Dai F; Xie S
Phytomedicine; 2021 May; 85():153530. PubMed ID: 33761445
[TBL] [Abstract][Full Text] [Related]
27. Dual effects for lovastatin in anaplastic thyroid cancer: the pivotal effect of transketolase (TKT) on lovastatin and tumor proliferation.
Wang CY; Shui HA; Chang TC
J Investig Med; 2018 Jun; 66(5):1-9. PubMed ID: 29502067
[TBL] [Abstract][Full Text] [Related]
28. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by down-regulation of aquaporin 5.
Zhang Z; Han Y; Sun G; Liu X; Jia X; Yu X
Cell Mol Biol Lett; 2019; 24():13. PubMed ID: 30805015
[TBL] [Abstract][Full Text] [Related]
30. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells.
Liu W; Huai R; Zhang Y; Rao S; Xiong L; Ding R; Mao C; Zhao W; Hao T; Huang Q; Guo Z
Genes Genomics; 2019 Aug; 41(8):951-959. PubMed ID: 31066006
[TBL] [Abstract][Full Text] [Related]
32. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
[TBL] [Abstract][Full Text] [Related]
33. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Zhou Y; Zhou N; Fang W; Huo J
Diagn Pathol; 2010 Sep; 5():58. PubMed ID: 20846397
[TBL] [Abstract][Full Text] [Related]
34. [Antitumor activity of lycorine in renal cell carcinoma ACHN cell line and its mechanism].
Huang YQ; Zhang YM; Jin Z; Li XZ; Wang CS; Xu K; Huang P; Liu CX
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):857-62. PubMed ID: 27320892
[TBL] [Abstract][Full Text] [Related]
35. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
36. CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients.
Yao Y; Su J; Zhao L; Li R; Liu K; Wang S
J Cancer; 2019; 10(27):6822-6828. PubMed ID: 31839816
[TBL] [Abstract][Full Text] [Related]
37. MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3.
Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B
Int J Oncol; 2015 Oct; 47(4):1585-93. PubMed ID: 26252738
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer.
Zhang L; Huang Z; Cai Q; Zhao C; Xiao Y; Quan X; Tang C; Gao J
Front Med (Lausanne); 2022; 9():837143. PubMed ID: 35280908
[TBL] [Abstract][Full Text] [Related]
40. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
